DR. BERNARD BENJAMIN LEVINE
Osteopathic Medicine at Riverside Dr, New York, NY
License number
New York 079818-1
Category
Osteopathic Medicine
Type
Allergy & Immunology
Address
Address
210 Riverside Dr, New York, NY 10025
Phone
(212) 865-6655
Personal information
See more information about BERNARD BENJAMIN LEVINE at radaris.comName
Address
Phone
5 Riverside Dr APT 7A, New York, NY 10023
5 Riverside Dr #1A, New York, NY 10023
55 Branch Ave #2N, Freeport, NY 11520
6907 224Th St, Flushing, NY 11364
555 Pinewoods Ave, Troy, NY 12180
Professional information
Owner At Fish Medicine Diagnostic Service
Position:
Owner at Fish Medicine Diagnostic Service
Location:
Greater New York City Area
Industry:
Veterinary
Work:
Fish Medicine Diagnostic Service
-
Owner
Education:
Rutgers, The State University of New Jersey-New Brunswick 1947 - 1951
BSinAgriculture, Poultry PathologyVMD degree 1955- University of Pennsylvania School of Veterinary Medicine
BSinAgriculture, Poultry PathologyVMD degree 1955- University of Pennsylvania School of Veterinary Medicine
Independent Biotechnology Professional
Location:
Greater New York City Area
Industry:
Biotechnology
Bernard Benjamin Levine, New York NY
Specialties:
Allergist
Address:
210 Riverside Dr, New York, NY 10025
Method And Composition For Testing To Predict And/Or Diagnose Allergy To Penicillins
US Patent:
4252784, Feb 24, 1981
Filed:
Aug 23, 1979
Appl. No.:
6/069149
Inventors:
Bernard B. Levine - New York NY
International Classification:
A61K 4900
US Classification:
424 9
Abstract:
The invention relates to the testing of humans or other animals, such as horses, cattle or dogs, for allergic reaction or hypersensitivity to penicillins. The tests can be used both to predict and to diagnose allergy. The invention comprises new penicilloyl-polylysine (PPL) preparations, and novel test methods employing such materials.
The new PPL preparations comprise homogeneous, high purity, maximally coupled,. alpha. -diastereoisomeric, penicilloyl conjugates of low molecular weight PPLs. The PPL materials of the invention have the molecular structure in accordance with the following generic formula: ##STR1## wherein: R is selected from the group consisting of H and penicilloyl groups or similar groups derived from cephalosporins or other. beta. -lactam antibiotics; and
n is an integer of from 4 to 10, at least about 66% and up to 100% of the R groups are other than hydrogen. Solutions containing this PPL material are useful in skin testing for penicillin allergy or hypersensitivity alone, but preferably are utilized in a two-part test with MDM solutions containing the novel MDM materials of the invention.
Composition And Method For Testing To Predict And/Or Diagnose Allergy To Penicillins
US Patent:
4228147, Oct 14, 1980
Filed:
May 9, 1979
Appl. No.:
6/037248
Inventors:
Bernard B. Levine - New York NY
International Classification:
A61K 2900, A61K 3143
US Classification:
424 9
Abstract:
The invention relates to the testing of humans or other animals, such as horses, cattle or dogs, for allergic reaction or hypersensitivity to penicillins. The tests can be used both to predict and to diagnose allergy. The invention comprises new penicilloyl-polylysine (PPL) preparations, new materials for use in minor determinant mixture (MDM) compositions and novel test methods employing such materials.
The new PPL preparations comprise homogeneous, high purity, maximally coupled,. alpha. -diastereoisomeric, penicilloyl conjugates of low molecular weight PPLs. The PPL materials of the invention have the molecular structure in accordance with the following generic formula: ##STR1## wherein: R is selected from the group consisting of H and penicilloyl groups or similar groups derived from cephaolosporins or other. beta. -lactam antibiotics; and
n is an integer of from 4 to 10,
at least about 66% and up to 100% of the R groups are other than hydrogen. Solutions containing this PPL material are useful in skin testing for penicillin allergy or hypersensitivity alone, but preferably are utilized in a two-part test with MDM solutions containing the novel MDM materials of the invention.
Compositions For Testing To Predict And/Or Diagnose Allergy To Penicillins
US Patent:
4316882, Feb 23, 1982
Filed:
Aug 30, 1979
Appl. No.:
6/071418
Inventors:
Bernard B. Levine - New York NY
International Classification:
A61K 4900
US Classification:
424 9
Abstract:
The invention relates to the testing of humans or other animals, such as horses, cattle or dogs, for allergic reaction or hypersensitivity to penicillins. The tests can be used both to predict and to diagnose allergy. The invention comprises new materials for use in minor determinant mixture (MDM) compositions and lyophilized, storage-stable MDM compositions and novel test methods employing such materials.
The new MDM materials are N-penicilloyl amines of an aliphatic amine or. alpha. -aminoacid having the following molecular structure: ##STR1## wherein: R. sub. 1 =a side chain which defines the type of penicillin--e. g. , where R. sub. 1 = ##STR2## the new material is a derivative of benzylpenicillin; and R. sub. 2 is an alkyl group of C. sub. 2 -C. sub. 6 length, preferably ethyl or propyl, or an aminoacid residue as described herein.
Method For Testing To Predict And/Or Diagnose Allergy To Penicillins, And Compounds And Compositions For Use In Such Tests
US Patent:
4183910, Jan 15, 1980
Filed:
Apr 20, 1978
Appl. No.:
5/898044
Inventors:
Bernard B. Levine - New York NY
International Classification:
C07D27706, C07D41712, A61K 3702, A61K 31425
US Classification:
424 9
Abstract:
The invention relates to the testing of humans or other animals, for allergic reaction or hypersensitivity to penicillins. The tests can be used both to predict and to diagnose allergy. The invention comprises new penicilloyl-polylysine (PPL) preparations, new materials for use in minor determinant mixture (MDM) compositions and novel test methods employing such materials.
The new PPL preparations comprise homogeneous, high purity, maximally coupled,. alpha. -diastereoisomeric, penicilloyl conjugates of low molecular weight PPLs. The PPL materials of the invention have the molecular structure in accordance with the following generic formula: ##STR1## wherein: R is selected from the group consisting of H and penicilloyl groups or similar groups derived from cephalosporins or other. beta. -lactam antibiotics; and
n is an integer of from 4 to 10,
at least about 66% and up to 100% of the R groups are other than hydrogen. Solutions containing this PPL material are useful in skin testing for penicillin allergy or hypersensitivity alone, but preferably are utilized in a two-part test with MDM solutions containing the novel MDM materials of the invention.